India’s Mankind Pharma Ltd. on Tuesday reported a 43.4% surge in fourth-quarter profit in the Manforce condom-maker’s first earnings as a listed company, helped by lower input costs.
https://www.pharmalive.com/wp-content/uploads/2023/05/ReutersMankind5-30-2023.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-05-30 10:37:102023-05-30 11:09:18India’s Mankind Pharma posts 43% jump in Q4 profit in first results since listing
